Regeneveda Chicago

Regeneveda Chicago operates under the medical direction of Thom E. Lobe, MD, FAARFM, ABAARM, a board-certified physician in anti-aging and regenerative medicine who brings specialized training in cellular therapeutics and peptide biology to patients throughout the Chicago, IL metropolitan area. The clinic focuses on regenerative medicine protocols that include peptide therapy, hormone optimization, and proprietary cell harvesting and banking services designed to preserve autologous cellular material for future therapeutic use. Dr. Lobe's credentials include fellowship training with the American Academy of Anti-Aging and Regenerative Medicine (FAARFM) and board certification through the American Board of Anti-Aging and Regenerative Medicine (ABAARM), positioning the practice to deliver evidence-informed interventions for age-related decline and metabolic dysfunction.

The peptide therapy program at Regeneveda Chicago incorporates bioregulatory peptides targeting growth hormone pathways, immune modulation, tissue repair, and metabolic function. Specific peptide protocols are selected based on individual patient labs, health history, and treatment goals, with common applications including muscle preservation during weight loss, recovery from musculoskeletal injury, cognitive support, and skin rejuvenation. Hormone therapy services extend beyond standard testosterone and estrogen replacement to include thyroid optimization, adrenal support, and growth hormone secretagogue protocols. The clinic's cell harvesting and banking service allows patients to cryopreserve their own stem cells and growth factors at a younger biological age, creating a personalized cellular reserve for potential future regenerative treatments as the science continues to evolve.

Dr. Lobe's clinical approach integrates comprehensive laboratory assessment with patient-reported outcomes to design individualized treatment plans. Initial consultations typically include detailed health history review, physical examination, and ordering of specialized labs that may include hormone panels, inflammatory markers, metabolic function tests, and cellular aging biomarkers. Follow-up protocols are structured around regular monitoring to assess treatment response and adjust peptide dosing, hormone levels, or adjunctive therapies as needed. The nursing staff at the Chicago location administers in-office treatments including peptide injections, IV nutrient therapy, and laser-based aesthetic procedures that complement the regenerative medicine protocols.

Patients at Regeneveda Chicago report positive experiences with the nursing team's technical skill and the clinic's focus on measurable results, particularly in the areas of body composition changes, energy improvement, and aesthetic outcomes from laser treatments. The clinic environment is designed for patients seeking proactive, science-based interventions rather than reactive sick care, attracting individuals interested in longevity medicine, athletic performance optimization, and age management. Treatment timelines vary by protocol, with peptide therapy courses typically running 12 to 24 weeks and hormone optimization requiring ongoing management with quarterly or semi-annual follow-ups.

Regeneveda maintains dual locations in Chicago, Illinois and Beverly Hills, California, allowing the practice to serve patients across both metropolitan areas with consistent protocols and standards of care. The Chicago clinic offers both in-person consultations and select telehealth follow-up appointments for established patients, though initial evaluations and procedures requiring in-office administration are conducted on-site. The cell banking service represents a unique offering in the Chicago regenerative medicine landscape, providing patients with a tangible investment in their future health through preservation of their own biological materials at optimal viability.